Sanofi Reports Uninspiring Q4 Sales Amid Skepticism On Dupixent’s COPD Potential

Revenues Fall Short Of Consensus

 
• By Ayisha Sharma
  
Woman with one thumb up and one thumb down against pink background, represents mixed views
The Mixed Results For Sanofi Left Analysts Lukewarm • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business